Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 15, Issue 12, Pages 1631-1644
Publisher
Informa UK Limited
Online
2015-11-11
DOI
10.1586/14737159.2015.1110021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
- (2015) M. P. Morelli et al. ANNALS OF ONCOLOGY
- Brain Tumor Mutations Detected in Cerebral Spinal Fluid
- (2015) W. Pan et al. CLINICAL CHEMISTRY
- Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma
- (2015) Jeng-Sen Tseng et al. Journal of Thoracic Oncology
- Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
- (2015) O. A. Zill et al. Cancer Discovery
- Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
- (2015) Filip Janku et al. Oncotarget
- BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease
- (2015) Filip Janku et al. Oncotarget
- Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?
- (2014) M. Ignatiadis et al. ANNALS OF ONCOLOGY
- Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
- (2014) F. Rothé et al. ANNALS OF ONCOLOGY
- Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
- (2014) G. R. Oxnard et al. CLINICAL CANCER RESEARCH
- Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
- (2014) J. A. Beaver et al. CLINICAL CANCER RESEARCH
- The evolution of the unstable cancer genome
- (2014) Rebecca A Burrell et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Identification of Double-stranded Genomic DNA Spanning All Chromosomes with MutatedKRASandp53DNA in the Serum Exosomes of Patients with Pancreatic Cancer
- (2014) Christoph Kahlert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Analytical Validation of BRAF Mutation Testing from Circulating Free DNA Using the Amplification Refractory Mutation Testing System
- (2014) Kyaw L. Aung et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
- (2014) Jean-Yves Douillard et al. Journal of Thoracic Oncology
- Clinical Utility of a Blood-Based BRAFV600E Mutation Assay in Melanoma
- (2014) D. J. Panka et al. MOLECULAR CANCER THERAPEUTICS
- Acquired resistance to EGFR-targeted therapies in colorectal cancer
- (2014) Beth O. Van Emburgh et al. Molecular Oncology
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
- (2014) Alain R Thierry et al. NATURE MEDICINE
- Mechanism-based cancer therapy: resistance to therapy, therapy for resistance
- (2014) P Ramos et al. ONCOGENE
- Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC
- (2014) Zhijie Wang et al. PLoS One
- Tumor clone dynamics in lethal prostate cancer
- (2014) S. Carreira et al. Science Translational Medicine
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Prospective Blinded Study of BRAF V600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders
- (2014) David M. Hyman et al. Cancer Discovery
- Circulating cell free DNA: Preanalytical considerations
- (2013) Safia El Messaoudi et al. CLINICA CHIMICA ACTA
- Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing
- (2013) David Wong et al. CLINICAL BIOCHEMISTRY
- Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival
- (2013) Ioanna Balgkouranidou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients
- (2013) Diego M Marzese et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- CirculatingBRAFV600Ein the Diagnosis and Follow-Up of Differentiated Papillary Thyroid Carcinoma
- (2013) C. Pupilli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia
- (2013) Simona Soverini et al. LEUKEMIA RESEARCH
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Marker Detection in Peripheral Blood for NSCLC Diagnosis
- (2013) Paola Ulivi et al. PLoS One
- Non-invasive prenatal testing for aneuploidy: current status and future prospects
- (2013) P. Benn et al. ULTRASOUND IN OBSTETRICS & GYNECOLOGY
- Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
- (2013) Ellen Heitzer et al. Genome Medicine
- LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
- (2012) Jan Dominik Kuhlmann et al. BMC CANCER
- Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury
- (2012) Hada Macher et al. CLINICA CHIMICA ACTA
- Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression
- (2012) H. Schwarzenbach et al. CLINICAL CANCER RESEARCH
- Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
- (2012) K.-L. G. Spindler et al. CLINICAL CANCER RESEARCH
- Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
- (2012) M. J. Higgins et al. CLINICAL CANCER RESEARCH
- Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
- (2012) K. C. A. Chan et al. CLINICAL CHEMISTRY
- Detection of TFPI2 Methylation in the Serum of Hepatocellular Carcinoma Patients
- (2012) Feng-Kai Sun et al. DIGESTIVE DISEASES AND SCIENCES
- The value of serial plasma nuclear and mitochondrial DNA levels in acute spontaneous intra-cerebral haemorrhage
- (2012) H.-C. Wang et al. EUROPEAN JOURNAL OF NEUROLOGY
- Transformation of non-tumor host cells during tumor progression: theories and evidence
- (2012) Dolores C García-Olmo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Prognostic role of methylated free circulating DNA in colorectal cancer
- (2012) Alexander B. Philipp et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities
- (2012) Nicola Normanno et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
- (2012) D. Hashad et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer
- (2012) Kang-Yi Su et al. JOURNAL OF CLINICAL ONCOLOGY
- The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
- (2012) Anneli Dowler Nygaard et al. LUNG CANCER
- Evolution of the cancer genome
- (2012) Lucy R. Yates et al. NATURE REVIEWS GENETICS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methylated DNA and Total DNA in Serum Detected by One-Step Methylation-Specific PCR Is Predictive of Poor Prognosis for Breast Cancer Patients
- (2012) Noriko Fujita et al. ONCOLOGY
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients
- (2011) Georg Göbel et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- A sensitive method to quantify human cell-free circulating DNA in blood: Relevance to myocardial infarction screening
- (2011) Rong-Rong Jing et al. CLINICAL BIOCHEMISTRY
- Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
- (2011) K. Taniguchi et al. CLINICAL CANCER RESEARCH
- The inverted pyramid of biomarker-driven trials
- (2011) Ignacio Garrido-Laguna et al. Nature Reviews Clinical Oncology
- High Fragmentation Characterizes Tumour-Derived Circulating DNA
- (2011) Florent Mouliere et al. PLoS One
- Prognostic Value of Circulating Mutant DNA in Unresectable Metastatic Colorectal Cancer
- (2010) Benoit Lefebure et al. ANNALS OF SURGERY
- Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
- (2010) Ruth E. Board et al. BREAST CANCER RESEARCH AND TREATMENT
- Plasma cell-free DNA in ovarian cancer
- (2010) Aparna A. Kamat et al. CANCER
- Cell-Free Nucleic Acids Circulating in the Plasma of Colorectal Cancer Patients Induce the Oncogenic Transformation of Susceptible Cultured Cells
- (2010) D. C. Garcia-Olmo et al. CANCER RESEARCH
- The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke
- (2010) Nai-Wen Tsai et al. CLINICA CHIMICA ACTA
- Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non-Small Cell Lung Cancer
- (2010) S. Wang et al. CLINICAL CANCER RESEARCH
- Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers
- (2010) Elisa Danese et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients
- (2010) Gayatri Sharma et al. LIFE SCIENCES
- EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
- (2010) Young Lim Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
- (2010) Alain R. Thierry et al. NUCLEIC ACIDS RESEARCH
- Levels of Circulating Cell-Free Nuclear and Mitochondrial DNA in Benign and Malignant Ovarian Tumors
- (2010) Rebecca R. Zachariah et al. OBSTETRICS AND GYNECOLOGY
- The Origin of Elevated Levels of Circulating DNA in Blood Plasma of Premature Neonates
- (2009) N. O. Tuaeva et al. Annals of the New York Academy of Sciences
- Detection and Monitoring of Cell-Free DNA in Blood of Patients with Colorectal Cancer
- (2009) Heidi Schwarzenbach et al. Annals of the New York Academy of Sciences
- Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients
- (2009) T. K.F. Yung et al. CLINICAL CANCER RESEARCH
- Fine-needle aspiration (FNA) biopsy: historical aspects.
- (2009) Aristidis Diamantis et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Comparison of Circulating Plasma DNA Levels between Lung Cancer Patients and Healthy Controls
- (2009) Kyong-Ah Yoon et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer
- (2009) Zhenbin Chen et al. PLoS One
- A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids
- (2009) H. Goldshtein et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer
- (2008) M. Frattini et al. CANCER LETTERS
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
- (2008) Raquel Catarino et al. DNA AND CELL BIOLOGY
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
- (2008) Steven J. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer
- (2008) Massimiliano Paci et al. LUNG CANCER
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
- (2008) C.-H. Yun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started